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INTRODUCTION
As societies age, the prevalence of age-related condi-
tions is expected to increase [1]. While there is as yet 
no widely-accepted consensus definition [2, 3], frailty 
is considered to be an age-associated syndrome of in-
creased vulnerability resulting in a propensity for ad-
verse healthcare outcomes [4]. Frailty is recognised 
as dynamic [5, 6] with a clearly identifiable prodromal 
state, usually referred to as pre-frailty [7]. Pre-frailty, 
before onset of established frailty, may be reversible [8] 
and has become a target for multi-domain interventions 
in community-dwelling older adults [7, 9-10]. Like frail-
ty, there is no accepted definition of pre-frailty; instead 
it is usually described by deficits on a frailty screening 
or classification instrument not reaching the threshold 
for frailty but not consistent with being non-frail or ro-
bust [7]. Recent systematic data suggests that frailty is 
prevalent in community-dwellers [11] including in Eu-
ropean Union (EU) Member States (MS) [12]. Data 
from previous systematic reviews also suggest that pre-
frailty is common with reported prevalence rates rang-
ing from 41.6-49.3%, depending on the setting and 
populations assessed [11,13]. 
Over recent years multiple prospective, mainly cohort 
studies of ageing, have investigated the epidemiology of 
frailty. Most use either the Fried frailty criteria, focusing 
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Abstract
Introduction. Frailty is a dynamic syndrome and may be reversible. Despite this, little is 
known about trajectories or transitions between different stages of frailty.
Methods. A systematic review was conducted, selecting studies reporting frailty trajec-
tories or transition states for adults in any settings in European ADVANTAGE Joint 
Action Member States.
Results. Only three papers were included. Data were from longitudinal community-
based cohorts in the United Kingdom, Netherlands and Italy. The English study inves-
tigated the effect of physical activity on the progression of frailty over a 10-year period. 
Two presented data on the proportion of participants experiencing at least one frailty 
transition over time (32.6% in the Italian sample aged ≥ 65 years followed for 4.4 years; 
34.3% in the Dutch sample aged 65-75 years, followed for 2 years).
Conclusions. Data on frailty trajectories and transition states were limited and hetero-
geneous. Well-designed prospective studies and harmonized approaches to data collec-
tion are now needed. 
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on a physical phenotype as derived from the Cardiovas-
cular Health Study (CHS) [14], or a Frailty Index (FI), 
based on the accumulation of deficits theory whereby 
individuals are scored on an index with the number of 
deficits present on the numerator and all possible defi-
cits from a fixed inventory on the denominator [15]. The 
latter is commonly used in cross-sectional and longitu-
dinal studies [16] and may be best to measure change 
over time [17]. Such longitudinal studies have shown 
that there is a natural or background rate of transition or 
deterioration in FI scores [18]. This differs between stud-
ies, with figures varying from a doubling of the FI score 
over 12.6 [19] to over 20 years [20]. Again, these rates 
may reflect the heterogeneity between samples [19]; 
rates of deficit accumulation over time are associated 
with increasing age [21], female gender [22] and lower 
socioeconomic status [23]. A gender paradox is evident 
with women more likely to accumulate but better able to 
tolerate deficits [22, 24]. In addition, a cohort effect has 
been postulated that may affect frailty trajectories; more 
recent cohorts, of equivalent age to previous ones, are 
living with higher levels of frailty, apparently driven by 
wealth disparities [23]. There may also be a ceiling effect, 
typically a maximum FI score of 0.70 [22, 25]. 
Despite its strong associations with age, frailty may 
not be inevitable and there is some, albeit limited, evi-
dence of reversibility [6]. Frailty is a separate syndrome 
not synonymous with multi-morbidity and chronic 
disease [26] and there is evidence that changes in the 
initial frailty cycle could be observed before onset of 
functional decline and disability [6]. Epidemiological 
studies offer the potential to demonstrate these com-
plex patterns to better understand them. Hence, the 
focus of recent research in this area is on recognising 
and describing the progression of frailty and identifying 
predictors likely to influence the transition to higher or 
lower frailty states, in order to appreciate the processes 
and dynamics underlying the development of frailty 
over time [27]; targeting these may allow appropriate 
public health systems’ processes (screening, monitoring 
and surveillance programmes) and interventions to be 
put in place [28]. 
The Joint Action (JA) on Frailty Prevention (AD-
VANTAGE) www.advantageja.eu is a co-funded project 
bringing together 33 partners from 22 EU MSs to de-
velop a comprehensive strategic framework for the pre-
vention and management of frailty in Europe. Although 
transitional states with bi-directional frailty trajectories 
are described in different countries and settings [5, 6], 
a clear understanding of these complex processes are 
still lacking. Given this, the aim of this study was to sys-
tematically review the scientific literature on trajecto-
ries and transitions between different stages of frailty in 
studies conducted in European JA ADVANTAGE MSs. 
MATERIALS AND METHODS
Search strategy
A systematic search of the available literature relat-
ing to frailty transitions and trajectories was conducted. 
PubMed/MEDLINE, Embase, CINAHL, Opengrey 
and the Cochrane library databases were searched for 
articles published over fifteen years between January 
2002 and April 2017. Grey literature and data from on-
going or unpublished studies were sought. In addition, 
the reference lists of relevant articles were searched 
for pertinent papers. The review was published on 
the Prospero database of systematic reviews, protocol 
CRD42017071866, and undertaken according to the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines [29]. The follow-
ing search terms with truncations were used to identify 
possible citations: “Trajectories” OR “Trajectory” OR 
“Transition*”; AND “Elderly” OR “Aged” OR “Older 
adult*” OR “Older person*” OR “Geriatric*” AND 
“Frailty”, OR “Frail”. 
Two pairs of reviewers independently screened cita-
tion’ titles and abstracts for possible inclusion and re-
moved all duplicates. Where required, a third reviewer 
settled disparities. Full papers were then retrieved and 
data from articles assessed as suitable for inclusion were 
extracted and analysed. 
Selection criteria
For the purpose of this systematic review, trajecto-
ries were defined as clusters of individuals following a 
similar progression of frailty over time [30] and transi-
tions were defined as changes between different stages 
of frailty over time (i.e. transition from robust, pre-frail, 
frail and back).
Papers were included only if they:
1) provided data relating to frailty using any accepted 
definition of frailty, irrespective of the screening or as-
sessment instrument used to describe frailty or one of 
its transition states i.e. non-frail or pre-frail;
2) studied adult participants who were aged ≥18 at 
baseline;
3) described frailty trajectories or transitions indepen-
dent of the setting the study was conducted in i.e. no 
restriction on setting provided the study was popula-
tion-based. Population-based papers were defined as 
studies where the results could be extrapolated to a 
larger population defined in terms of e.g. age groups, 
geographical areas, or clinical setting.
4) described trajectories or transition states as defined 
a priori;
5) reported results exclusively from, and in any of the 
languages of, the 22 JA MSs; 
6) published results between January 2002 and April 
2017. Before 2002, relevant studies were only consid-
ered on a case-by-case basis when discovered opportu-
nistically i.e. through searching reference lists.
Papers were excluded if they: 
a) contained replicated data from the same study;
b) only provided data from a country that was not in-
cluded among the 22 JA MSs; 
c) were reported in a language other than that of a JA MS;
d) were published as conference abstracts, editorials 
and correspondence;
e) did not relate specifically to the topic or were not 
population based.  
RESULTS
In total, 864 records were retrieved after the litera-
ture search and review of the grey literature. After the 
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removal of duplicates, 581 abstracts were screened. 
Of these, 3 full-text articles met inclusion criteria and 
were reviewed. The PRISMA flow diagram is presented 
in Figure 1. Most studies on trajectories or transitions 
between different stages of frailty were reported from 
non-JA MSs. The majority reported data from longitu-
dinal population-based cohort studies. In all, only three 
papers presenting data on frailty trajectories or transi-
tions from JA ADVANTAGE MSs were available. These 
were from the United Kingdom (UK) (n = 1) [31], It-
aly (n = 1) [32] and the Netherlands (n = 1) [33]. The 
characteristics of these studies are provided in detail in 
Table 1. In summary, two of the studies (in the UK and 
Italy) were community-based longitudinal studies [31, 
32]; the Dutch study recruited patients from primary 
care [33]. The Italian and Dutch studies analysed frailty 
transitions, both providing data on the proportion of 
participants having at least one transition during the 
period of follow-up; the UK study provided data on the 
association between trajectories and physical activity. 
There was considerable variation in frailty instruments 
used; the Italian study used Fried’s CHS criteria, the 
UK paper a 56-item FI and the Dutch study used the 
15-question Groningen Frailty Indicator (GFI). 
The UK study presented data on trajectories from 
the English Longitudinal Study of Ageing (ELSA) 
over the period from 2002 and 2010 [31]. The results 
showed that there were higher levels of frailty in women 
compared with men and that these differences persist-
ed over time. The study found that moderate physical 
activity reduced the progression of frailty in some age 
groups, particularly those aged ≥ 65 and that vigorous 
activity significantly reduced the trajectory of frailty. 
However, mild physical activity was insufficient to slow 
progression [31]. The results also described the influ-
ence of socioeconomic factors on frailty trajectories 
with those in lower socioeconomic groups more likely 
to transition to frailty. The Progetto Veneto Anziani 
(Pro.V.A.) Longitudinal Study from Italy, found that 
32.6% of participants had at least one frailty transition 
in any direction over 4.4 years of follow-up [32]. The 
authors identified several risk factors for transitions 
including older age, female gender, obesity, cardiovas-
cular disease, osteoarthritis, hypovitaminosis D, hyper-
uricemia, smoking, vision loss, dependence in activities 
of daily living, cognitive impairment, low monthly in-
come and poor physical performance, all of which were 
significantly associated with greater risk of becoming 
frail at end-point [32]. Improvements in frailty status in 
participants who were frail or pre-frail at baseline were 
associated with being overweight, having low-moderate 
alcohol consumption, higher educational level and 
living alone [32]. In the Personalised ICT Supported 
Service for Independent Living and Active Ageing 
(PERSSILAA) Study, older adults attending their gen-
eral practitioner in the Enschede region of the Nether-
lands were screened with the GFI to categorise frailty 
at baseline and end-point over two years of follow-up 
[33]. The study found that most robust participants at 
baseline (78%) remained robust. Over half (52%) of 
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Figure 1
PRISMA flow diagram of the systematic review of studies of frailty trajectories or transition states at population level in the Joint 
Action ADVANTAGE European Member States.
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participants who were pre-frail or frail also remained 
stable. It was found that 26% of frail participants tran-
sitioned back to pre-frail while 25% of pre-frail partici-
pants transitioned to robust. Overall, 23% of the older 
adults examined converted from pre-frailty to estab-
lished frailty over two years, and 34.3% (58/169) had at 
least one frailty transition in any direction. However, as 
highlighted by the PERSSILAA investigators, the num-
bers were small, duration of follow-up short and the 
classification of frailty based on the GFI, which may 
have been overly sensitive to change. 
DISCUSSION
The results of this systematic review of frailty tra-
jectories and transitions in JA MSs showed that avail-
able data were limited. The three studies found were 
extremely heterogeneous; one reporting trajectories 
and two providing data on transitions between different 
frailty states. Both papers reporting transitions provid-
ed the proportion of participants with at least one frailty 
transition noted during the period of follow-up. Indeed, 
while both studies reported data on a various array of 
possible transition states from robust (non-frail) to pre-
frail, frail and back, this was the only consistent indica-
tor. Findings appeared roughly similar; in the Pro.V.A 
Longitudinal study the proportion of participants with 
any frailty transition was 32.6% [32] versus 34.3% in 
PERSSILAA [7, 33] in cohorts both aged over 65 years. 
However, the duration of follow-up over which these 
outcomes were investigated varied markedly (ranging 
from 2 to 4.4 years) between studies, limiting compara-
bility. Further, these also differed in sampling approach, 
Table 1
Characteristics of studies reporting transitions or trajectories of frailty at population-level in the Joint Action ADVANTAGE Euro-
pean Member States
Author, year Number of 
participants
Age
(years)
Women
(%)
Setting &
Design
Frailty 
definition
Sampling 
process
Results
UK
Rogers et al., 
2017 [31]
8649 ≥50 53.2 Community 
based 
Longitudinal 
cohort study
FI, 
56 variables 
Representative 
sample of the 
population aged 
50 and over, 
living in private 
households in 
England.
Average eleven-year frailty 
trajectories in five-year 
age cohorts (50-54; 55-
59; 60-64; 65-69; 70-74; 
75-79; 80+) of non-frail 
adults were assessed, 
predicted by baseline 
physical activity (PA) 
status. Compared with the 
sedentary reference group, 
mild PA was insufficient 
to significantly slow the 
progression of frailty, 
moderate physical activity 
reduced the progression of 
frailty in some age groups 
(particularly ages 65 and 
above) and vigorous activity 
significantly reduced the 
trajectory of frailty.
Italy
Trevisan et al., 
2017 [32]
2925 ≥65 59.7 Community 
based 
Longitudinal 
cohort study
Fried criteria 
(CHS) 
Randomly 
selected using 
a multistage 
stratified method.
Over 4.4 years of follow-
up, 41.9% retained their 
baseline frailty status, 32.6% 
had one transition in their 
frailty status, and 25.5% 
died. 
The Netherlands
O’Caoimh et al., 
2017 [33]
169 ≥65 52 Primary care
Longitudinal 
cohort study
GFI Sampling from 
a representative 
sample of patients 
attending general 
practitioners 
offices. Two-
step screening 
and assessment 
process.
Only those with 
baseline and 
end-point data 
included.
During two years of 
follow-up, 78% of subjects 
remained robust, while 
over half remained stable 
as pre-frail (52%) or frail 
(52%). About a quarter 
transitioned back from 
either frail to pre-frail 
(26%) and from pre-frail 
to robust (25%). In all, 23% 
converted from pre-frailty 
to established frailty over 
two years (2014-2016). In 
all, 34.3% had one frailty 
transition.
CHS:  Cardiovascular Health Study; FI: Frailty Index; GFI:  Groningen Frailty Indicator
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frailty classification, sample size and population char-
acteristics.
This heterogeneity is similar to that reported in non-
JA countries, where the proportions with any transition 
also vary considerably. The most consistent measure of 
progression reported appears to be the proportion of in-
dividuals with at least one frailty transition during follow-
up, which has been reported to be as low as 22% over six 
years using the Vulnerable Elders Survey-13 questionnaire 
in a sample with a mean age of 79 years in Israel [34] to 
61% over ten years using the Fried’s CHS criteria in per-
sons with a mean age of 78 years in the United States 
of America (USA) [35]. Acute illness and hospitalisation 
were identified in the USA [36] and polypharmacy in 
Australia [37] as the most common precipitating factors 
resulting in transitions to more severe frailty states.  
Since this systematic review was conducted several 
new studies have been published, including an analy-
sis from the Longitundinal Aging Study Amsterdam 
examining trajectories in those aged ≥65 years [19]. 
This paper presents mean changes in a 32-item FI score 
(including factors from physical, mental and cognitive 
domains) over 17 years. It could be argued that the 
use of such a sensitive, comprehensive, adaptable and 
continuous measure will allow for greater comparability 
[17], especially if this approach to capturing trajectories 
is more widely used.
Using similar frailty classifications and instruments is 
one approach to standardising results to provide more 
accurate and reliable data on trajectories and transi-
tions. Developing broader consensus definitions on not 
only frailty but also pre-frailty are required to facilitate 
this [7]. There is also a need for well-designed prospec-
tive studies and harmonised approaches to gather reli-
able information on the epidemiology and progression 
of frailty. Ongoing longitudinal studies of ageing includ-
ing the international Survey of Health and Retirement 
in Europe (SHARE) [38] and the Study on Global 
AGEing and Adult Health (SAGE) [39], which collect 
frailty data, are a good example of this. Nevertheless, 
these kinds of studies are subject to attrition bias, which 
may lead to relatively less frail samples over time and 
underestimation of rates at different time points, partic-
ularly if participants are followed over the prolonged pe-
riods necessary to demonstrate changes [40] especially 
at the early pre-frailty stage. Cohort effects may also 
introduce bias where different waves are considered in 
longitudinal data sets [19].  
It is also important to conduct studies examining 
predictors of transitions to higher (or lower) levels of 
frailty, including those associated with more rapid tra-
jectories. To date, a number of risk factors have been 
identified, which apart from age and gender, include 
a wide variety of social and behavioural factors [23]. 
These were echoed in the Italian study by Trevisan et 
al. [32], which highlighted the association between 
these and frailty transitions. Understanding how these 
determine rates of change including their impact on re-
versibility will also be important, particularly if evidence 
grows for the potential to improve frailty and transition 
to lower frailty states. Indeed, whether frailty is truly 
reversible remains a topic of discussion for over twenty 
years with little evidence yet available from population-
level studies measuring frailty progression over time. 
Growing research is focused on preventing onset in 
community-dwellers at risk (i.e. pre-frail older adults) 
[7, 10]. However, while there is evidence that pre-frailty 
can be reduced in community-dwelling older adults [9], 
there is little evidence that this applies to those with 
established frailty, even in its early stages [41].
This study has several limitations. The focus was on 
EU JA countries as this was the remit of ADVANTAGE 
and no detailed analysis or meta-analysis was possible 
because of the paucity of papers retrieved in this con-
text. Including papers from other countries, particularly 
the USA and Japan, where most studies examining 
frailty trajectories have been conducted, would allow 
a better insight into the topic, although this could in-
troduce even more heterogeneity. Our search only in-
cluded papers published since 2002 and our review of 
the grey literature in particular was not exhaustive so 
that some relevant studies may not have been included. 
Given the increased research focus on frailty trajecto-
ries and transitions and the growing number of publica-
tions dedicated to this, repeating this review in a global 
context would be worthwhile.
CONCLUSIONS
Few studies examining frailty trajectories or transi-
tions were available from EU ADVANTAGE JA MSs. 
Given the importance of this information in planning 
public health interventions, there is a need to better 
support data collection and projects that measure frailty 
trajectories and transitions between different levels of 
frailty severity at population-level in the EU. Existing 
data from ongoing longitudinal studies of ageing such 
as SHARE and SAGE might be used to better under-
stand these in Europe. More data on predictors and risk 
factors for transitions are also required; better knowl-
edge about these can foster policy action to reduce 
frailty at population-level. Agreement on the timing of 
suitable intervals to assess frailty trajectories is impor-
tant and recommendations to standardise these should 
be made. Well-designed incidence studies should also 
help inform this. Again, developing standardised ap-
proaches to defining and measuring frailty is important 
to ensure comparability of findings globally and across 
JA ADVANTAGE MSs.
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